(CALC)

NCM – Real vaqt narxi. Valyuta: USD

0.57

-0.01 (-2.32%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

0.58

+0.01 (1.93%)

Bozordan keyin: Mar 27, 2026, 6:47 PM EDT

Kompaniya haqida

CalciMedica, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, yallig'lanish va immunologik jarayonlar hamda to'g'ridan-to'g'ri hujayra shikastlanishi natijasida kelib chiqqan kasalliklar uchun terapevtik vositalarni ishlab chiqadi. Uning yetakchi mahsulot nomzodi Auxora, o'tkir pankreatit, asparaginaza bilan bog'liq pankreatik toksiklik va o'tkir buyrak shikastlanishi, shuningdek, COVID-19 dan kelib chiqqan og'ir pnevmoniyani davolash uchun tomir ichiga yuboriladigan kichik molekulali kaltsiy chiqaruvchi faollashtirilgan kaltsiy (CRAC) kanal inhibitörlerini o'z ichiga oladi. Kompaniya, shuningdek, Auxorani yarali kolit, travmatik miya shikastlanishi va allergik astmani davolash uchun; va surunkali yallig'lanish va immunologik kasalliklarda qo'llash uchun og'iz orqali qabul qilinadigan CRAC kanal inhibitorlarini ishlab chiqadi. Kompaniya La Jolla, Kaliforniyada joylashgan.

Asosiy rahbarlar

Ism	Lavozim
Dr. A. Rachel Leheny Ph.D.	CEO & Director
Dr. Anjana Rao Ph.D.	Co-Founder and Scientific Advisor
Dr. Kenneth A. Stauderman Ph.D.	Co-Founder & Chief Scientific Officer
Dr. Patrick Hogan Ph.D.	Co-Founder and Scientific Advisor
Dr. Stefan Feske M.D.	Co-Founder and Scientific Advisor
Dr. Sudarshan Hebbar M.D.	Chief Medical Officer
Mr. Eric W. Roberts	Chief Business Officer & Vice Chairman of the Board